Locate Bio Closes £10 Million Funding Round

04 Sep, 2021

Locate Bio Closes £10 Million Funding Round
Photo by Alejandro Escamilla on Unsplash

– Locate Bio is pleased to announce that it has raised an oversubscribed £10 million of equity investment in a funding round co-led by existing shareholder Mercia Asset Management and new investor BGF.
– The funding will be used to further advance Locate Bio’s proprietary pipeline of regenerative orthobiologics products towards patients, with key clinical and regulatory milestones expected to catalyse growth over the next two years.
– The investment brings the total funds raised by Locate Bio to over £18 million. The company’s lead product in development is called LDGraft, and is a low dose, controlled release rhBMP-2 for the treatment of degenerative disc disease.

Biotechnology Medical Device Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: